Endovascular

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

20 min.

Drug-Coated Balloons BTK: What’s the Latest in the Field?

17 min.

Vascular Drug Delivery: Distilling the Paclitaxel Controversy

10 min.

Real World Evidence About Paclitaxel Safety

9 min.

Patient-Level Meta-analysis on Paclitaxel Safety

9 min.

FDA Opinion About Lessons Learned From the Paclitaxel Controversy

16 min.

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

22 min.

Role of Drug-Eluting Technologies as Definitive Therapy

8 min.

Reflow Medical’s Temporary Spur DES System

3 min.

Hybrid Nano-Coating DES for BTK Disease

6 min.

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

7 min.

Have We Gotten to the Final Word on Paclitaxel Safety?

9 min.